Bericht
Competition law and access to medicines: Lessons from Brazilian regulation and practice
Competition law may play an important role in drug pricing control by containing high prices derived from economic violations. Since the use of competition tools is not limited by the TRIPS Agreement or other international binding disciplines, there is ample policy room to explore how countries, especially in the Global South, can benefit from strengthening their jurisdiction on that matter. This article briefly explains the Brazilian Competition System by describing the structure of the Brazilian competition authority (CADE - Administrative Council for Economic Defense) and the main economic violations set forth by Brazilian law. It describes the convergence of competition with the consumer protection system. It also discusses three relevant pharmaceutical market cases examined by the competition authority (sham litigation, overpricing and economic abuse, buy-and-raise and exclusionary practices). Finally, it presents some lessons from the Brazilian case on the challenges of using competition law to confront abuse or misuse of intellectual property rights in the pharmaceutical market, with lessons to other developing countries.
- Sprache
-
Englisch
- Erschienen in
-
Series: Research Paper ; No. 142
- Klassifikation
-
Sozialwissenschaften, Soziologie, Anthropologie
- Thema
-
Wettbewerbsrecht
Preisregulierung
Immaterialgüterrechte
Arzneimittelmarkt
Gesundheitsversorgung
Arzneimittel
Brasilien
- Ereignis
-
Geistige Schöpfung
- (wer)
-
Falcão, Matheus Z.
Gondo, Mariana
Navarrete, Ana Carolina
- Ereignis
-
Veröffentlichung
- (wer)
-
South Centre
- (wo)
-
Geneva
- (wann)
-
2022
- Handle
- Letzte Aktualisierung
-
10.03.2025, 11:44 MEZ
Datenpartner
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Bericht
Beteiligte
- Falcão, Matheus Z.
- Gondo, Mariana
- Navarrete, Ana Carolina
- South Centre
Entstanden
- 2022
Ähnliche Objekte (12)
Brazilian competition law and access to health in Brazil: Exploitative pricing in the pharmaceutical sector
Guidelines on patentability and access to medicines
The international debate on generic medicines of biological origin
Regional pooled procurement of medicines in the East African community
Intellectual property, public health and access to medicines in international organizations
Medicines and intellectual property: 10 years of the WHO global strategy
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Access to medicines and intellectual property: The contribution of the World Health Organization
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
The African Regional Intellectual Property Organization (ARIPO) protocol on patents: Implications for access to medicines
Intellectual property in the Trans-Pacific Partnership: Increasing the barriers for the access to affordable medicines
Brazilian competition law and access to health in Brazil: Exploitative pricing in the pharmaceutical sector
Guidelines on patentability and access to medicines
The international debate on generic medicines of biological origin
Regional pooled procurement of medicines in the East African community
Intellectual property, public health and access to medicines in international organizations
Medicines and intellectual property: 10 years of the WHO global strategy
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Access to medicines and intellectual property: The contribution of the World Health Organization
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
The African Regional Intellectual Property Organization (ARIPO) protocol on patents: Implications for access to medicines
Intellectual property in the Trans-Pacific Partnership: Increasing the barriers for the access to affordable medicines
Brazilian competition law and access to health in Brazil: Exploitative pricing in the pharmaceutical sector
Guidelines on patentability and access to medicines
The international debate on generic medicines of biological origin
Regional pooled procurement of medicines in the East African community
Intellectual property, public health and access to medicines in international organizations
Medicines and intellectual property: 10 years of the WHO global strategy
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Patent analysis for medicines and biotherapeutics in trials to treat COVID-19
Access to medicines and intellectual property: The contribution of the World Health Organization
The Potential Impacts of Nano-Scale Technologies on Commodity Markets: The Implications for Commodity Dependent Developing Countries
The African Regional Intellectual Property Organization (ARIPO) protocol on patents: Implications for access to medicines